Details of the Drug Combination
General Information of Drug Combination (ID: DCTARK5)
Drug Combination Name |
PFK-158 Hyodeoxycholic acid
|
|||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indication |
|
|||||||||||||||||
Component Drugs | PFK-158 | Hyodeoxycholic acid | ||||||||||||||||
N.A. | N.A. | |||||||||||||||||
2D MOL | 2D MOL | |||||||||||||||||
3D MOL | 3D MOL | |||||||||||||||||
High-throughput Screening Result | Testing Cell Line: KBM-7 | |||||||||||||||||
Zero Interaction Potency (ZIP) Score: 13.87 | ||||||||||||||||||
Bliss Independence Score: 13.87 | ||||||||||||||||||
Loewe Additivity Score: 17.49 | ||||||||||||||||||
LHighest Single Agent (HSA) Score: 17.51 | ||||||||||||||||||
Molecular Interaction Atlas of This Drug Combination
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indication(s) of PFK-158 |
|
||||||||||||||||||||||||||||||
PFK-158 Interacts with 1 DTT Molecule(s)
|
|||||||||||||||||||||||||||||||
Hyodeoxycholic acid Interacts with 2 DME Molecule(s)
|
|||||||||||||||||||||||||||||||
References